Form 4: Pacira BioSciences COO Daryl Gaugler Sells 500 Shares Under 10b5-1 Plan

Pacira BioSciences' Chief Operating Officer, Daryl Gaugler, sold 500 shares of common stock at $12.86 per share under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On September 13, 2024, Daryl Gaugler, the Chief Operating Officer of Pacira BioSciences, Inc. (PCRX), sold 500 shares of the company's common stock.
• The transaction was executed at a price of $12.86 per share.
• The sale was conducted under a Rule 10b5-1 trading plan previously adopted by Gaugler.
• Following the transaction, Gaugler directly owns 115,699.952 shares of Pacira BioSciences common stock.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing related to an insider stock sale under a pre-arranged plan. It doesn't inherently convey positive or negative sentiment about the company's performance or prospects.

Industry Context

Insider sales are a common occurrence in publicly traded companies. The use of a 10b5-1 trading plan allows insiders to sell shares at predetermined times and prices, avoiding accusations of trading on non-public information. Investors often monitor insider transactions for signals about a company's prospects, but sales under 10b5-1 plans are generally viewed as less informative than discretionary trades.

Stakeholder Impact

• The sale of shares by a company executive could be perceived neutrally or slightly negatively by shareholders, depending on their individual investment strategies and interpretations of insider trading activity.

Key Dates